Middle East Pharmaceutical Industries Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mohammed Maher Al-Ghannam
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.2yrs |
| CEO ownership | n/a |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO
Mohammed Maher Al-Ghannam (43 yo)
6.2yrs
Tenure
Mr. Mohammed Maher MohammedLotfi Al-Ghannam is MD & Director of Middle East Pharmaceutical Industries Company from April 10, 2022 and its CEO from September 5, 2018. He was Director of Operations at the Mi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 6.2yrs | no data | no data | |
| Chief Financial Officer | 5.7yrs | no data | no data | |
| Chief Operating Officer | 1.4yrs | no data | no data | |
| Director of the Scientific Office Department | 6.8yrs | no data | no data | |
| Executive Director of Administrative Affairs | 5.8yrs | no data | no data | |
| Marketing Director | 2.3yrs | no data | no data | |
| Vice President of Sales | 2.3yrs | no data | no data | |
| Director of Human Resources | 1.4yrs | no data | no data | |
| Secretary of the Board of Directors | 1.2yrs | no data | no data |
2.3yrs
Average Tenure
43yo
Average Age
Experienced Management: 4016's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 2.6yrs | no data | no data | |
| Independent Non-Executive Director | 1.7yrs | no data | no data | |
| Independent Deputy Chairman | 1.2yrs | no data | no data | |
| Chairman | 2.6yrs | no data | no data | |
| Independent Non-Executive Director | 2.6yrs | no data | no data |
2.6yrs
Average Tenure
52yo
Average Age
Experienced Board: 4016's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.